Y020-8920 Screening compound: 2-[2-(3,4-dimethoxyphenyl)ethyl]-8-(1H-1,2,4-triazol-5-yl)-1H,2H,8H,9H-pyrido[4,3-b]1,6-naphthyridine-1,9-dione

Y020-8920 Screening compound: 2-[2-(3,4-dimethoxyphenyl)ethyl]-8-(1H-1,2,4-triazol-5-yl)-1H,2H,8H,9H-pyrido[4,3-b]1,6-naphthyridine-1,9-dione
Y020-8920 Screening compound: 2-[2-(3,4-dimethoxyphenyl)ethyl]-8-(1H-1,2,4-triazol-5-yl)-1H,2H,8H,9H-pyrido[4,3-b]1,6-naphthyridine-1,9-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound Y020-8920
2-[2-(3,4-dimethoxyphenyl)ethyl]-8-(1H-1,2,4-triazol-5-yl)-1H,2H,8H,9H-pyrido[4,3-b]1,6-naphthyridine-1,9-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y020-8920

Molecular Formula

C23H20N6O4 (C23 H20 N6 O4)

Compound Name

2-[2-(3,4-dimethoxyphenyl)ethyl]-8-(1H-1,2,4-triazol-5-yl)-1H,2H,8H,9H-pyrido[4,3-b]1,6-naphthyridine-1,9-dione

IUPAC name

2-[2-(34-dimethoxyphenyl)ethyl]-8-(1H-124-triazol-5-yl)-1H2H8H9H-pyrido[43-b]16-naphthyridine-19-dione

SMILES

COc(ccc(CCN(C=Cc(c1c2)nc(C=CN3c4ncn[nH]4)c2C3=O)C1=O)c1)c1OC

InChI

InChI=1S/C23H20N6O4/c1-32-19-4-3-14(11-20(19)33-2)5-8-28-9-6-17-15(21(28)30)12-16-18(26-17)7-10-29(22(16)31)23-24-13-25-27-23/h3-4,6-7,9-13H,5,8H2,1-2H3,(H,24,25,27)

InChI Key

CSBTXRYRKAWAAQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD13757732

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

444.45

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

1.759

Distribution Coefficient, logD

1.751

Water Solubility, LogSw

-2.36

Polar Surface Area

92.165

Acid Dissociation Constant (pKa)

9.17

Base Dissociation Constant (pKb)

2.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

17.40

Y020-8920 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-Inflammatory Library (24602 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with Y020-8920 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y020-8920?
Check Price and Availability of Y020-8920, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y020-8920 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y020-8920
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y020-8920
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y020-8920 available by request